<DOC>
	<DOCNO>NCT02637934</DOCNO>
	<brief_summary>Up 30 woman know suspected epithelial ovarian , fallopian tube , primary peritoneal cancer participate two different image cohort . The Biodistribution cohort include 10 patient Dynamic cohort include 20 patient . Human dosimetry calculate Biodistribution cohort . The Dynamic cohort date evaluate preliminary information uptake [ 18F ] FTT gynecological cancer compare PARP-1 activity tissue .</brief_summary>
	<brief_title>Phase I Pilot Study Biodistribution , Metabolism Excretion Novel Radiotracer 18FFluorthanatrace ( FTT ) PET/CT</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria Biodistribution cohort Participants ≥ 18 year age History know suspect epithelial ovarian , fallopian tube , primary peritoneal cancer ( may primary metastatic cancer time study enrollment ) At least one lesion ≥ 1.0 cm see standard imaging ( e.g . CT , MRI , ultrasound , FDG PET/CT ) Participants must inform investigational nature study willing provide write informed consent participate study accordance institutional federal guideline prior studyspecific procedure . Exclusion Criteria Biodistribution cohort Females pregnant breast feeding time screen eligible study ; urine pregnancy test perform woman childbearing potential screening . Inability tolerate image procedure opinion investigator treat physician Any current medical condition , illness , disorder assess medical record review and/or selfreported consider physician investigator condition could compromise participant safety successful participation study Inclusion Criteria Dynamic cohort Participants ≥ 18 year age History know suspect epithelial ovarian , fallopian tube , primary peritoneal cancer ( may primary recurrent cancer time study enrollment ) At least one lesion ≥ 1.0 cm see standard imaging ( e.g . CT , MRI , ultrasound , FDG PET/CT ) Clinical plan biopsy surgical procedure least one site know suspected cancer Willing consent collection pathology tissue purpose research time clinical biopsy surgical procedure . Participants must inform investigational nature study willing provide write informed consent participate study accordance institutional federal guideline prior studyspecific procedure . Exclusion Criteria Dynamic cohort Females pregnant breast feeding time screen eligible study ; urine pregnancy test perform woman childbearing potential screening . No clinical plan biopsy surgical procedure know suspected cancer Inability tolerate image procedure opinion investigator treat physician Any current medical condition , illness , disorder assess medical record review and/or selfreported consider physician investigator condition could compromise participant safety successful participation study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>